{"organizations": ["Perrigo Company plc", "Perrigo Company"], "uuid": "9e9699e3ea729de85308cd396e8bdbf06febe31f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Perrigo-Company-plc-To-Release-Third-Quarter-Calendar-Year-2015-Results-On-October-22--2015-49071-1/", "country": "US", "title": "Perrigo Company plc To Release Third Quarter Calendar Year 2015 Results On October 22, 2015", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Perrigo Company plc To Release Third Quarter Calendar Year 2015 Results On October 22, 2015", "spam_score": 0.0, "site_type": "news", "published": "2015-10-19T11:14:00.000+03:00", "replies_count": 0, "uuid": "9e9699e3ea729de85308cd396e8bdbf06febe31f"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Perrigo-Company-plc-To-Release-Third-Quarter-Calendar-Year-2015-Results-On-October-22--2015-49071-1/", "ord_in_thread": 0, "title": "Perrigo Company plc To Release Third Quarter Calendar Year 2015 Results On October 22, 2015", "locations": ["DUBLIN"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "RSS Navigation Links HOME >> MEDICINE >> TECHNOLOGY Perrigo Company plc To Release Third Quarter Calendar Year 2015 Results On October 22, 2015 ... DUBLIN Oct. 19 2015 /- P...The conference call will be available live via webcast to interested p... About Perrigo !-- Paragraph before: Perrigo Company plc is...Perrigo Company plc is a top five global over-the-counter ( OTC ) cons... http://feeds.bio-medicine.org/latest-medical-technology Date:10/19/2015 \nDUBLIN , Oct. 19, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO ; TASE) today announced that it will release financial results for its third quarter calendar year 2015 on Thursday, October 22, 2015 at approximately 6:00 a.m. (ET). The Company will conduct a conference call at 8:00 a.m. (ET) hosted by Joseph C. Papa , Perrigo's Chairman, President and Chief Executive Officer. \nThe conference call will be available live via webcast to interested parties in the investor relations section of the Perrigo website at http://perrigo.investorroom.com/events-webcasts or by phone at 877-248-9413, International 973-582-2737, and reference ID #54344799. A taped replay of the call will be available beginning at approximately 4:00 p.m. (ET) Thursday, October 22, until midnight Friday, November 6, 2015. To listen to the replay, dial 855-859-2056, International 404-537-3406, and use access code 54344799. \nAbout Perrigo \nPerrigo Company plc is a top five global over-the-counter (\"OTC\") consumer goods and leading specialty pharmaceutical company, offering patients and customers high- quality products at affordable prices. From the Company's beginning in 1887 as a packager of home remedies, it has grown to become the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market. The Company is also a leading provider of generic extended topical prescription products, and it receives royalties from sales of the multiple sclerosis drug Tysabri®. The Company provides \"Quality Affordable Healthcare Products®\" across a wide variety of product categories and geographies, primarily in North America , Europe and Australia , as well as in other markets, including Israel and China . Visit Perrigo online at ( http://www.perrigo.com ). \nForward-Looking Statements \nCertain statements in this presentation are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as \"may,\" \"will,\" \"could,\" \"would,\" \"should,\" \"expect,\" \"plan,\" \"anticipate,\" \"intend,\" \"believe,\" \"estimate,\" \"predict,\" \"potential\" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates and projections. While the Company believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These and other important factors, including those discussed under \"Risk Factors\" in the Perrigo Company's Form 10-K for the year ended June 28, 2014, as well as the Company's subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this presentation are made only as of the date hereof, and unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.", "external_links": [], "published": "2015-10-19T11:14:00.000+03:00", "crawled": "2015-10-19T23:40:35.262+03:00", "highlightTitle": ""}